Physician profile
Kenneth N Moates
NPI 1336135581
$1,821.32
in general payments reported to CMS, 2019-2025
16 companies · $613 in 2025
The $613 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.16 · 2020: $315 · 2021: $206 · 2022: $126 · 2023: $189 · 2024: $298 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,100.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $422.53 | 2019-2021 | |
| Abbvie INC. | $377.88 | 2022-2025 | |
| Alcon Vision LLC | $300.98 | 2020-2025 | Total30, Precision7, Dailies |
| Tarsus Pharmaceuticals, INC. | $191.55 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $128.66 | 2022-2025 | Oxervate |
| Amgen INC. | $111.19 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $90.86 | 2022-2023 | Infuse |
| Thea Pharma INC. | $35.36 | 2023-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $29.97 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.75 | 2020 | |
| Ani Pharmaceuticals, INC. | $23.49 | 2025 | Purified Cortrophin Gel |
| Astellas Pharma US INC | $20.69 | 2023 | Izervay |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Coopervision INC. | $19.30 | 2022 | |
| Oyster Point Pharma, INC. | $15.46 | 2025 | Tyrvaya |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $10.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Moates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.